The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

by Miller Andrew F, Beck Adam W, Sullivan Laura A, Dineen Sean P, Carbon Juliet G, Mamluk Roni, Wong Henry, Brekken Rolf A
Published 2008-11-01